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ABSTRACT
Introduction: Heliotropium indicum has several
uses in traditional medicine attributable to its
numerous bioactive compounds. It is used as a
traditional remedy for cataracts in Ghana
without any scientific verification. This study
aimed at verifying the anti-cataract properties of
an aqueous whole plant extract of H. indicum.
Methods: The effect (cataract score) of 30, 100,
and 300 mg kg-1 extract (bid for 21 days, per os)
on the development of 30 lmol kg-1 sodium
selenite-induced cataract in 10-day-old rat pups
was investigated. Soluble lens proteins alpha A
and alpha B crystallins, total lens protein, total
lens glutathione, and aquaporin 0 in enucleated
lens homogenates were determined
spectrophotometrically using commercially
available kits. Histopathological studies on
the lenses were also performed. The
2,2-diphenyl-1-picrylhydrazyl scavenging effect
and linoleic acid autoxidation (antioxidant
properties) of the extract (0.1–3.0 mg ml-1),
compared to n-propyl gallate, were ascertained
using standard procedures.
Results: Cataract scores showed that the
extract, at all dose levels, significantly
alleviated selenite-induced cataracts
(P B 0.001). Markers of lens transparency
(aquaporin 0, alpha A and B crystallins), as
well as total lens proteins and lens glutathione
levels, were significantly preserved
(P B 0.01–0.001). The extract exhibited activity
relevant for scavenging free radicals and
inhibition of lipid peroxidation. Epithelial and
lens fiber integrity in the histopathological
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assessment were maintained with HIE
treatment.
Conclusion: The aqueous whole plant extract
of H. indicum significantly inhibited the
development of cataracts in rats via multiple
mechanisms.
Keywords: Alpha A and alpha B crystallins;
Aquaporin 0; Cataract; DPPH scavenging effect
INTRODUCTION
Heliotropium indicum (Family: Boraginaceae) has
long been used in traditional medicine for the
treatment of several ailments not only in Ghana
but also in several other parts of the globe [1]. Its
medicinal prowess has led to several scientific
investigations into its pharmacological activity
and the isolation of several alkaloids of
pharmacological importance. Notable among
these alkaloids are indicine, indicine-N-oxide,
acetyl-indicine, indicinine, heleurine,
heliotrine, supinine, supinidine, and
lindelofidine [2–7]. Some of these bioactive
compounds, such as indicine-N-oxide, have
gained attention for their anti-cancer properties
despite safety concerns [6].
With the advances made in investigating
H. indicum’s bioactivity in managing various
systems disorders, its traditional uses as an
antidote for ocular disorders such as
conjunctivitis, uveitis, and cataract remain
largely unverified [8, 9].
Against the backdrop that cataracts remain
the leading cause of blindness in the world, and
the number one cause of ocular morbidity
among the elderly with limited management
options (only surgery is approved), claims and
unverified reports of potential anti-cataract
agents deserve attention [10, 11]. This search
for alternative treatment for chronic disorders
such as cataracts has rejuvenated scientists’
interest in plant medicine as a possible source
of remedy, some of which have made their way
into mainstream allopathic medicine. Examples
of these plant-derived medications include
atropine, muscarine, and physostigmine [12].
However, amidst all these developments,
plant-based pharmaceuticals are still largely
untapped. Of the estimated 250,000–500,000
plant species, only a small percentage have been
investigated phytochemically and an even
smaller percentage have been well studied
regarding their pharmacological action [13].
This highlights the need for rigorous scientific
research into the botanicals used in traditional
medicine as a basis for developing novel
medication to cater for unmet medical needs.
Based on this assertion, this study sought to
conduct an initial investigation aimed at
examining the anti-cataract claims of H.
indicum commonly used either orally (whole
plant) or topically (leaves) by some Ghanaian
people to ascertain the veracity of this claim.
METHODS
Plant Collection
Heliotropium indicum was collected from the
botanical gardens of the University of Cape
Coast (5.1036 N, 1.2825 W), Cape Coast, in
theCentral Region of Ghana, inNovember 2012.
It was identified and authenticated by a botanist
at theUniversity ofCapeCoast herbarium,where
a voucher specimen bearing the number 4873
has been deposited for future reference.
Preparation of the Aqueous Whole Plant
Extract of H. indicum
Whole plants of H. indicum were washed
thoroughly with tap water and shade dried.
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The dry plants were milled into a coarse powder
by a hammer mill (Schutte Buffalo, New York,
NY, USA). One and a half kilograms of the plant
powder was mixed with one liter of water. The
mixture was Soxhlet extracted at 80 C for 24 h.
The aqueous extract obtained was freeze-dried
(Hull freeze-dryer/lyophilizer 140 SQ,
Warminster, PA, USA). The powder (yield
12.2%), labeled as whole plant extract of H.
indicum (HIE), was stored at 4 C and
reconstituted in normal saline to the desired
concentration for dosing in this study.
Drugs and Chemicals
Sodium selenite, Na2SeO3 (Sigma Aldrich,
Germany), was used to induce cataracts.
Tropicamide 1% ophthalmic solution [Alcon
Laboratories South Africa (Pty) Ltd] was used to
dilate the pupil of the eye at every slit-lamp
examination.
2,2-Diphenyl-1-picrylhydrazyl(DPPH),
methanol, ethanol, sodium phosphate,
n-propyl gallate, linoleic acid (BDH, Poole,
UK), trichloroacetic acid, and thiobarbituric
acid (Sigma-Aldrich, St. Louis, MO, USA) were
used in the antioxidant assays.
Animals and Husbandry
Ten-day-old Sprague–Dawley rat pups of either
sex (mean weight of 24 ± 2 g) were kept in the
Animal House of the School of Biological
Sciences, University of Cape Coast. The pups
(and their mothers) were housed in polyacrylic
cages (34 9 47 9 18 cm) with soft wood
shavings as bedding, under ambient laboratory
conditions (temperature 28 ± 2 C, relative
humidity 60–70%, and a normal light–dark
cycle). The mothers were fed on a normal
commercial pellet diet (Agricare Ltd., Kumasi,
Ghana) and had access to water ad libitum.
Ethical and Biosafety Considerations
The study protocol was approved by the
Institutional Review Board on Animal
Experimentation, Faculty of Pharmacy and
Pharmaceutical Sciences, Kwame Nkrumah
University of Science and Technology, Kumasi,
Ghana (Ethical Clearance Number: FPPS/PCOL/
0030/2013). All activities performed during the
studies conformed to accepted principles for
laboratory animal use and care (EU directive of
1986: 86/609/EEC) and Association for Research
in Vision and Ophthalmology Statement for
Use of Animals in Ophthalmic and Vision
research. Biosafety guidelines for the
protection of personnel in the laboratory were
observed.
Preliminary Phytochemical Screening
Screening was performed on HIE to ascertain
the presence of phytochemicals using standard
procedures described by Harborne [14] and
Kujur et al. [15].
Effect of HIE on Selenite-Induction
of Cataract in Pups
Ten-day-old rat pups were injected
subcutaneously with 15 lmol kg-1 sodium
selenite in normal saline daily for 2 days. The
pups were then put into four groups (n = 8, i.e.,
the number of rats per group). Groups I–IV
received 30, 100, 300 mg kg-1 HIE, and
10 mL kg-1 normal saline, respectively, per os,
30 min after the first selenite injection. These
doses were used based on preliminary studies to
establish activity in our laboratory. Treatment
was then given twice daily (12 h) for 21 days. A
fifth group (V) made up of normal pups given
no selenite injection nor treatment was also
kept under same experimental conditions as a
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normal control. On day 21 after selenite
injection, the pupils of the pups’ eyes were
dilated using 1% tropicamide ophthalmic
solution and assessment of the crystalline lens
for developing cataract made using a Marco II-B
Slit Lamp (Marco-Lombart Instrument, Japan).
The developing cataracts were then graded and
scored after repeating the experiment on three
different occasions.
Grading and Scoring of Cataract
Two researchers (SK and CAH) individually
graded the lens opacification (masked and in a
random order) as in Table 1. The grades were
then scored and expressed as the percentage of
total lenses in each group using the following
formula:
% cataract
¼ number of cataractous eyes per group
total number of eyes per group
 100
Determination of Lens Glutathione
The total glutathione (GSH) in the crystalline
lens was determined using a commercially
acquired kit (Cayman Chemicals, Ann Arbor,
MI, USA). The lenses from the enucleated eye of
the rats were rinsed with phosphate-buffered
saline (PBS), pH 7.4, to remove any blood clots.
They were then homogenized in 5 mL of 50 mM
MES (2-(N-morpholino) ethanesulfonic acid,
pH 7), using Precellys 24 tissue homogenizer
(Bertin Technologies, France). The lens
homogenate was centrifuged at 100,000g for
15 min at a temperature of 4 C, after which the
supernatant was deproteinated using
metaphosphoric acid and 4 M triethanolamine
according to the manufacturer’s instructions. A
50 lL volume of the deproteinated lens samples
and the standards (constituted per the
manufacturer’s directive) were pipetted into a
96-well microtiter plate and read at 405 nm
with a URIT-660 microplate reader (URIT
Medical Electronic Co., Ltd, Guangxi, China)
after incubation in the dark on an orbital shaker
for 30 min. Each determination was done in
triplicate.
Determination of Total Lens Protein
Concentration
A bicinchoninic acid (BCA) protein assay kit
(Pierce, Rockford, IL, USA) was used to establish
the total protein concentration in the lens
homogenate obtained from the enucleated rat
eyes. For total protein estimation, the lens
homogenate was prepared in 5%
trichloroacetic acid. The precipitated protein
was dissolved in 5% sodium hydroxide and used
as aliquots for the estimation of total proteins.
The protein concentration was determined by
pipetting 50 lL of lens homogenate from: rats
treated with 30, 100, and 300 mg kg-1 of HIE,
Table 1 Grading and scoring of selenite-induced cataract in lenses of Sprague–Dawley rats
Grade Description Score
Clear lens 0
I Swollen lens ﬁbers and subcapsular opacities 1
II Nuclear cataract was observed in the lens but swollen ﬁbers were still visible in the lens cortex 2
III Strong nuclear cataract with peri-nuclear area opacity in the lens 3
IV Total opacity of the lens 4
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and 10 mL kg-1 normal saline; normal rats
without selenite injection; and standard
bovine serum albumin (BSA) into a 96-well
microplate. A 200 lL volume of working
reagent, constituted according to the
manufacturer’s instructions, was mixed
thoroughly with the content of each well and
shaken for 30 s. It was then incubated at 37 C
for 30 min and allowed to cool to room
temperature. Absorbances of the mixtures were
measured at 562 nm using an URIT-660
microplate reader. Each determination was
done in triplicate.
Determination of Soluble Lens Protein
Soluble lens proteins were determined using a
commercially available ELISA kits
(MyBioSource, Inc., San Diego, CA, USA).
Soluble lens protein levels, mainly alpha A
(CRYAA) and alpha B (CRYAB), were estimated
after the lens tissue was rinsed with PBS,
homogenized in 1 mL of 1X PBS, and stored
overnight at -20 C. After two freeze–thaw
cycles were performed to break the cell
membranes, the homogenates were
centrifuged for 5 min at 5000g and 2–8 C. The
supernatant was removed and assayed
immediately. A 100 lL of standard and sample
per well was constituted, covered with an
adhesive strip, and incubated for 2 h at 37 C.
Several other intermittent incubations were
done in accordance with the manufacturer’s
instructions. Absorbances of the mixtures were
measured at 450 nm using a URIT-660
microplate reader. Each determination was
done in duplicate.
Determination of Aquaporin 0
A commercial kit which uses a double-antibody
sandwich enzyme-linked immunosorbent
one-step process assay (ELISA; MyBioSource,
Inc., MBS 028997) was used to assay the level
of aquaporin 0 (AQP0) in lens homogenate
samples. Standard, test sample, and HRP-labeled
AQP0 antibodies were pipetted into the enzyme
wells which are pre-coated with AQP0 antibody.
These were then incubated (at 37 C in the dark
at different time periods as specified by the
manufacturer) and washed manually with
de-ionized water using a Pasteur pipette to
remove the uncombined enzyme. Upon adding
Chromogen Solution A and B, the color of the
liquid changed to blue and finally to yellow after
adding the stop solution. The optical density
(OD) was then measured at 450 nm using a
URIT-660 microplate reader. Based on the
concentration standards and their
corresponding OD values, a standard curve
linear regression equation was computed. From
this curve, the OD values of the sample on the
regression equation were used to calculate the
corresponding sample’s concentration.
Histopathological Assessment
The extracted lenses from enucleated eyes of the
animals were fixed in 10% phosphate-buffered
paraformaldehyde and embedded in paraffin.
Sections were made and stained with
hematoxylin and eosin [16], and fixed on glass
slides for microscopic examination at the
Department of Biomedical and Forensic
science, University of Cape Coast, Cape Coast,
for histopathological assessment by an
experimental pathologist.
Antioxidant Property of HIE
Free Radical Scavenging Assay
This procedure was performed as previously
described by Govindarajan et al. [17] with
few modifications. Concentrations of
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0.1–3.0 mg mL-1 HIE in 99.8% methanol were
selected and compared with
0.001–0.03 mg mL-1 n-propyl gallate in
methanol (reference free radical scavenger).
HIE was centrifuged at 3000g for 10 min. One
milliliter of the supernatant was added to 3 mL
of a 20 mg L-1 methanolic DPPH solution and
kept at 25 C for 1 h in an orbital shaker
(BoroLabs, Aldermaston, Berkshire, UK). A
1 mL quantity of 99.8% methanol (control)
was added to 3 mL DPPH solution and
incubated under the same conditions. The
absorbance of the residual DPPH was
determined at 517 nm in a Cecil CE 2040
spectrophotometer (Cecil Instruments Limited,
Cambridge, UK). Methanol was used as the
blank. The procedure was done in triplicate and
the results expressed as percentage DPPH
scavenging effect against concentration. The
half maximal inhibitory concentration (IC50)
values were established.
Linoleic Acid Autoxidation
The method previously described by Mitsuda
et al. [18] was used. Concentrations of
0.1–3.0 mg mL-1 HIE in 96% ethanol were
compared with 0.001–0.03 mg ml-1 n-propyl
gallate (reference antioxidant) in 96% ethanol.
Two milliliter quantities each of the ethanolic
HIE and n-propyl gallate mixtures were put into
separate screw cap test tubes. 2.05 mL of 2.51%
linoleic acid (in 96% ethanol), 4 mL of 0.05 M
phosphate buffer (pH 7.0), and 1.9 mL of
distilled water were then added to the test
tube and placed in an oven at 40 C in the dark
for 7 days. To 2 mL each of the HIE and the
n-propyl gallate mixture prepared and
incubated, 2 mL of 20% trichloroacetic acid
(aq) solution and 1 mL of 0.6% thiobarbituric
acid (aq) solution were added. The mixtures
were placed in a boiling water bath for 10 min,
cooled, and centrifuged at 3000 g for 10 min.
The absorbances of the supernatant were
measured and the percentage inhibition of
linoleic acid autoxidation was calculated using
the following formula:
% inhibition ¼ C0  C1ð Þ  ðDD0  C0ÞðC0  C1Þ  100
where C0 (full reaction mixture) is the degree of
lipid peroxidation in the absence of
antioxidant; C1 is the underlying lipid
peroxidation before the initiation of lipid
peroxidation; D is any absorbance produced by
the extract being tested; and D0 is the
absorbance of the extract alone.
Statistical Analysis
Statistical analysis of the data obtained was
done using GraphPad Prism version 5.0
(GraphPad Software, Inc., La Jolla, CA, USA).
Differences between treatment groups and the
controls were estimated using one-way analysis
of variance (ANOVA) followed by Dunnet’s
multiple comparisons test (post hoc test) at a
confidence level of 95%. Probability values B5%
(P B 0.05) were considered significant.
RESULTS
Phytochemical Screening
Preliminary phytochemistry showed that
flavonoids, saponins, cyanogenic glycosides,
sterol, tannins, and alkaloids were present in
HIE (Table 2).
Effect of HIE on Selenite-Induced
Cataracts
Slit-lamp assessment revealed that normal
saline-treated pups had 10 of the 16 eyes
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(62.5%) developed total cataract (grade IV),
with the remaining 6 (37.5%) having strong
nuclear cataract (grade III). Meanwhile, only
one 30 mg kg-1 HIE-treated rat (2 eyes, 12.5%)
had grade I cataracts, while the remaining 14
eyes (87.5%) had clear lenses. HIE showed the
greatest activity against selenite-induced
cataracts at the highest dose of 300 mg kg-1
(i.e., none had cataracts). Nevertheless, the
100 mg kg-1 HIE-treated eyes had only 6
lenses out of the 16 without cataract (4 eyes
had grade IV cataracts, 2 eyes had grade III
cataracts, and 4 eyes had grade II cataracts).
None of the normal control rats had cataracts
(Fig. 1). The cataract scores showed that HIE at
all dose levels significantly (P B 0.001)
alleviated cataracts induced with sodium
selenite (Fig. 1).
Effect of HIE on Lens GSH
HIE activity against cataracts was supported by
the significantly high levels of GSH in the
HIE-treated eyes compared to the normal
saline-treated eyes (P B 0.01–0.001; Fig. 2).
Total Lens Protein and Soluble Protein
Concentration
Estimation of total lens protein and soluble lens
protein was consistently indicative of the
degree of lens transparency. There were
significantly high concentrations of total
protein, CRYAA, and CRYAB depending on the
transparency of the lens (P B 0.01–0.001;
Table 3).
Aquaporin 0 Levels in the Lens
The estimated levels of AQP0 water channel,
whose permeability is tightly regulated in
healthy lenses, was significantly high
indicating they were preserved when treated
with the extract (P B 0.001; Fig. 3).











? Present; - absent
Fig. 1 The effects of 30, 100, and 300 mg kg-1 HIE, and
10 mL kg-1 NS on selenite-induced cataractous in
Sprague–Dawley rats. Values plotted are mean ± standard
error of the mean (n = 8). ***P B 0.001; ANOVA
followed by Dunnett’s post hoc test. NORM normal
control, NS normal saline, HIE whole plant extract of
Heliotropium indicum
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Free Radical Scavenging Effect
and Linoleic Acid Autoxidation Assay
HIE showed a concentration-dependent
scavenging activity in a similar manner to
n-propyl gallate. The IC50 values obtained for
HIE and n-propyl gallate were 5.85 and
1.12 mg ml-1, respectively (Fig. 4). Both
n-propyl gallate and HIE showed
concentration-dependent inhibition of linoleic
acid autoxidation with IC50 values of 1.02 and
2.78 mg ml-1, respectively (Fig. 5).
Histopathological Assessment
The histopathological assessment showed that
the integrity of the lens epithelium (which is
instrumental in lens homeostasis) was
preserved, and, at the same time, the
architecture of the lens fibers in all HIE-treated
rats and normal rats was also maintained.
However, there was observable epithelial
erosion of the lens and abnormal morphology
of the lens fibers (Fig. 6).
DISCUSSION
Selenite-induced cataract is a common model of
senile cataract employed in preclinical studies
for screening potential anti-cataract agents [19].
Overdose of this salt has been hypothesized to
cause cataracts by a series of processes which
includes: alteration of epithelial cell
metabolism [20], enhanced oxidative stress
[21], impairment of calcium homeostasis
[22–24], apoptosis [25, 26], DNA damage [27],
activation of m-calpain [28], and
Fig. 2 The effects of 30, 100, and 300 mg kg-1 of HIE,
and 10 mL kg-1 NS on GSH levels in selenite-induced
cataractous Sprague–Dawley rats. Values plotted are
mean ± standard error of the mean (n = 8). **P B 0.01;
***P B 0.001; ANOVA followed by Dunnett’s post hoc
test. GSH glutathione, NORM normal control, NS normal
saline, HIE whole plant extract of Heliotropium indicum
Table 3 Total lens protein and soluble protein levels of controls and HIE-treated cataractous Sprague–Dawley rats
Treatment Lens proteins
Total protein (lg mL21) CRYAA (pg mL21) CRYAB (pg mL21)
10 mL kg-1 NS 2135 ± 158.0 167.3 ± 13.14 84.30 ± 3.303
NORM 4369 ± 108.1*** 673.2 ± 43.09*** 153.7 ± 3.303***
30 mg kg-1 HIE 3500 ± 39.67*** 515.5 ± 34.77*** 153.7 ± 3.303***
100 mg kg-1 HIE 2915 ± 167.0** 331.6 ± 22.76** 117.3 ± 8.739**
300 mg kg1 HIE 3545 ± 83.48*** 719.2 ± 6.571*** 160.3 ± 5.721***
Values are mean ± SEM (n = 8). **P B 0.01; ***P B 0.001; ANOVA followed by Dunnett’s post hoc test
CRYAA alpha crystallin A, CRYAB alpha crystallin B, NS normal saline, NORM normal control
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insolubilization of proteolyzed b- and
a-crystallins [29].
Although the 100 mg kg-1 HIE dose showed
a slight drop in activity relative to the 30 and
300 mg kg-1 doses, its observed clinical effect is
desirable since a delay in cataract formation is
known to prevent severe visual disability that
could affect the independence of most people
affected [30]. It has been projected that a delay
in cataract formation of approximately 10 years
would lessen the burden of a visually disabling
cataract by approximately 45% [19]. Such a
delay, as shown by 100 mg kg-1 HIE, has the
potential to enhance the quality of life for most
of the world’s elderly population at risk of
cataract, and to considerably moderate both the
economic burden due to disability and surgery
related to cataract after further studies regarding
isolation, structural elucidation, and efficacy
have been performed.
Safeguarding the lens from oxidative stress,
and the consequent maintenance of
transparency, is ensured by endogenous
antioxidant systems that consist of
non-enzymatic and enzymatic machinery.
Human senile or experimental cataractogenesis
is linked with a progressive decline in lenticular
GSH [31, 32]. For that reason, it has been
hypothesized that GSH plays a key role in
maintaining lens physiology and transparency
Fig. 3 The effects of 30, 100, and 300 mg kg-1 HIE, and
10 mL kg-1 NS on AQP0 levels in selenite-induced
cataractous Sprague–Dawley rats. Values plotted are
mean ± standard error of the mean (n = 8).
***P B 0.001; ANOVA followed by Dunnett’s post hoc
test. AQP0 aquaporin 0, NORM normal control, NS
normal saline, HIE whole plant extract of Heliotropium
indicum
Fig. 4 Free radical scavenging ability of n-propyl gallate
(0.001–0.03 mg mL-1) and HIE (0.1–3 mg mL-1) in a
DPPH free radical assay. Values plotted are mean ± stan-
dard error of the mean (n = 3). DPPH
2,2-diphenyl-1-picrylhydrazyl, HIE whole plant extract of
Heliotropium indicum
Fig. 5 Percentage inhibition of linoleic acid autoxidation
by n-propyl gallate (0.001–0.03 mg mL-1) and HIE
(0.1–3 mg mL-1). Values plotted are mean ± standard
error of the mean (n = 3). HIE whole plant extract of
Heliotropium indicum
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Fig. 6 Photomicrographs showing normal and selenite-in-
duced cataractous rats treated with various doses of HIE or
normal saline (control). a Normal lens showing regular
arrangement of equatorial sections of outer lens cortex lens
ﬁber interspersed with nuclei. b Selenite-induced catarac-
tous lens with 30 mg kg-1 HIE treatment showing intact
cuboidal epithelium of the lens surface, normal subcapsular
epithelial margin, and lens ﬁber nuclei. c Selenite-induced
cataractous lens with 10 ml kg-1 normal saline treatment
(control) showing a virtually eroded epithelial margin and
distorted lens ﬁber morphology. d Selenite-induced
cataractous lens with 100 mg kg-1 HIE treatment indi-
cating a partially eroded epithelium and moderate mild
changes in lens ﬁber morphology. e Selenite-induced
cataractous lens with 300 mg kg-1 HIE treatment showing
preserved cuboidal epithelium of the lens surface and
normal subcapsular epithelial margin. HIE whole plant
extract of Heliotropium indicum
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by protecting sulfhydryl groups from oxidation
[33, 34]. The acknowledged impact of oxidative
damage in the pathology of cataracts, and in the
aging process, has shifted attention to
antioxidant therapy. Flavonoids and tannin in
general have been proven to possess
antioxidant activity relevant for scavenging
free radicals and to inhibit lipid peroxidation
[35–37].
The series of biochemical alterations that
take place in selenite-induced cataractogenesis
include the reduction of total soluble proteins
of lens and loss of total protein concentration
[38]. This presupposes that selenite-induced
cataractogenesis affects the whole lens
transport system. Selenite has again been
reported to inhibit protein synthesis in test
tube and human subjects after repeated
exposures [39, 40]. The conservation of the
total protein concentration in the lens of the
extract treated indicates that it is exerts it
anti-cataract effect by preventing the
inhibition of protein synthesis in the lens.
Moreover, selenium salt (i.e., sodium selenite)
causes a loss of a-crystallins (a major protein
component of the vertebrate eye lens) which
have been found to exert a chaperone activity
by binding to unfolded or denatured proteins
and suppressing nonspecific aggregation [41].
This chaperone role helps to avert the
development of large light-scattering
aggregates, inactivation of oxidative enzymes,
and probable cataractogenesis [42, 43]. The
extract treatment preserved the a-crystallin A
and B in the right molar concentration of three
to one [44]. This high concentration of total
lens protein and water-soluble proteins in their
right proportion is necessary for the
maintenance of the optimum refractive index
[45].
Gradual but persistent deterioration of lens
tissue occurs as a pathophysiological
consequence of malfunctioning water and
nutrient exchange via channel and transporter
proteins. These transporter proteins are crucial
because of the avascular nature of the
crystalline lens which may not survive on
diffusion alone [46]. AQP0, also known as
major intrinsic polypeptide (MIP), constitutes
more than 60% of the total membrane protein
content of fiber cells [47]. Aquaporins form
channels for water permeability across
biological membranes by high caliber
6-transmembrane helices that bring together a
hydrophilic water-conducting pore [48]. AQP0
serves as a model to appreciate how water
channels are regulated at the molecular level
[48]. The preservation of the AQP0 content of
the lens via the extract treatment contributed to
the maintenance of the lens transparency.
The possible mechanism of the anti-cataract
effect of HIE is not definitive as there are
multiple bioactive ingredients which may have
either synergistic or antagonist effects
depending on the dose. This possible
interaction is predictive from the relative drop
in effect of the 100 mg kg-1 to the other doses
and deserves further investigation.
CONCLUSIONS
The aqueous extract of H. indicum has
anti-cataract activity on selenite-induced
cataracts in Sprague–Dawley rats and maybe
useful as an anti-cataract agent for human
cataracts after further studies.
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